Use of atypical antipsychotic drugs in patients with dementia

scientific article

Use of atypical antipsychotic drugs in patients with dementia is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID12800962

P2093author name stringTimothy J Lacy
Charles D Motsinger
Gregory A Perron
P433issue11
P921main subjectdementiaQ83030
P304page(s)2335-2340
P577publication date2003-06-01
P1433published inAmerican Family PhysicianQ4743731
P1476titleUse of atypical antipsychotic drugs in patients with dementia
P478volume67

Reverse relations

cites work (P2860)
Q43788567A markov model of the cost effectiveness of olanzapine treatment for agitation and psychosis in Alzheimer's disease
Q38015698Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?
Q42622024Long-term effects of rivastigmine treatment on the need for psychotropic medications in nursing home patients with Alzheimer's disease : results of a 52-week open-label study
Q46421706Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study.
Q42133419Psychotic symptoms in the elderly
Q50885299Senile Dementia from Neuroscientific and Islamic Perspectives.
Q96303202The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use

Search more.